4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Xu, Hao ^a   Krolikowski, John G ^a   Jones, Deron W ^a   Ge, Zhi Dong ^a   Pagel, Paul S ^b   Pritchard, Kirkwood A ^a   Weihrauch, Dorothée ^a  

^a Children's Research Institute ^*  (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLASPARTYLTRYPTOPHANYLPHENYLALANYLLYSYLALANYLPHENYLALANYLTYROSYLASPARTYLLYSYLVALYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYLGLUTAMYLALANYLPHENYLALANINEAMIDE; ANTIINFLAMMATORY AGENT; INTERFERON REGULATORY FACTOR 5; PHOSPHOSERINE; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; FIBROSIS; FLUORESCENCE; HEART; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; MOUSE; MYOCARDITIS; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84871341765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052046     Document Type: Article

References (38)

1. Xu H, Zaidi M, Struve J, Jones DW, Krolikowski JG, et al. (2011) Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. American Journal of Physiology.Cell Physiology 300: C550-6.
2. Bocchieri MH, Henriksen PD, Jimenez SA, Kasturi KN, Muryoi T, et al. (1991) Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis & Rheumatism 34: 599-605.
3. Weihrauch D, Xu H, Shi Y, Wang J, Brien J, et al. (2007) Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice. American Journal of Physiology.Heart and Circulatory Physiology 293: H1432-41.
4. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, et al. (2004) Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109: 3215-3220.
5. Navab M, Anantharamaiah G, Reddy ST, Van Lenten BJ, Buga GM, et al. (2007) Peptide mimetics of apolipoproteins improve HDL function. Journal of Clinical Lipidology 1: 142-147.
6. Charles-Schoeman C, Banquerigo ML, Hama S, Navab M, Park GS, et al. (2008) Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis. Clinical Immunology 127: 234-244.
7. Navab M, Ananthramaiah G, Reddy ST, Van Lenten BJ, Ansell BJ, et al. (2004) Thematic review series: The pathogenesis of atherosclerosis the oxidation hypothesis of atherogenesis: The role of oxidized phospholipids and HDL. Journal of Lipid Research 45: 993-1007.
8. Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, et al. (2008) Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. Journal of Lipid Research 49: 2302-2311.
9. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature 434: 243-249.
10. Anda KS, Gómez-Martín D, Díaz-Zamudio M, Alcocer-Varela J (2011) Interferon regulatory factors: Beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmunity Reviews.
11. Hu G, Barnes BJ, (2009) IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. Journal of Biological Chemistry 284: 2767-2777.
12. Couzinet A, Tamura K, Chen HM, Nishimura K, Wang Z, et al. (2008) A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in fas-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America 105: 2556-2561.
13. Nelson TJ, Ge ZD, Van Orman J, Barron M, Rudy-Reil D, et al. (2006) Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. The Anatomical Record.Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 288: 1216-1224.
14. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, et al. (2009) Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 110: 317.
15. Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, et al. (2004) Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 109: 2343-2348.
16. Orikasa C, Kondo Y, Hayashi S, McEwen BS, Sakuma Y, (2002) Sexually dimorphic expression of estrogen receptor β in the anteroventral periventricular nucleus of the rat preoptic area: Implication in luteinizing hormone surge. Proceedings of the National Academy of Sciences 99: 3306-3311.
17. Wilhelm JE, Buszczak M, Sayles S, (2005) Efficient protein trafficking requires trailer hitch, a component of a ribonucleoprotein complex localized to the ER in Drosophila. Developmental Cell 9: 675-685.
18. Pardridge WM, Boado RJ, (1991) Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEBS Letters 288: 30-32.
19. Concepcion J, Witte K, Wartchow C, Choo S, Yao D, et al. (2009) Label-free detection of biomolecular interactions using biolayer interferometry for kinetic characterization. Combinatorial Chemistry & High Throughput Screening 12: 791-800.
20. Bruick RK, McKnight SL, (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science Signalling 294: 1337.
21. Kawai T, Akira S, (2007) TLR signaling. 19: 24-32.
22. Balkhi MY, Fitzgerald KA, Pitha PM, (2010) IKKα negatively regulates IRF-5 function in a MyD88-TRAF6 pathway. Cellular Signalling 22: 117-127.
23. Balkhi MY, Fitzgerald KA, Pitha PM, (2008) Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Molecular and Cellular Biology 28: 7296-7308.
24. Ahmed SS, Tan FK, Arnett FC, Jin L, Geng YJ, (2006) Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis & Rheumatism 54: 2250-2262.
25. Hu G, Mancl ME, Barnes BJ, (2005) Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA Damage-Induced apoptosis and cell death. Cancer Research 65: 7403.
26. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, et al. (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. Journal of Clinical Investigation 98: 785.
27. Vecoli C, Cao J, Neglia D, Inoue K, Sodhi K, et al. (2011) Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice. Journal of Cellular Biochemistry 112: 2616-2626.
28. Handattu SP, Garber DW, Monroe CE, van Groen T, Kadish I, et al. (2009) Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of alzheimer's disease. Neurobiology of Disease 34: 525-534.
29. Colonna M, (2007) TLR pathways and IFN-regulatory factors: To each its own. European Journal of Immunology 37: 306-309.
30. Sharif R, Mayes MD, Tan FK, Gorlova OY, Hummers LK, et al. (2012) IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Annals of the Rheumatic Diseases.
31. Wool GD, Vaisar T, Reardon CA, Getz GS, (2009) An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. Journal of Lipid Research 50: 1889-1900.
32. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, et al. (2011) The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. The Journal of Biological Chemistry 286: 3839-3850.
33. Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, et al. (2008) The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation. The Journal of Biological Chemistry 283: 16752-16761.
34. Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, et al. (2003) L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation 107: 2337-2341.
35. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 101: 6062.
36. Krolikowski J, Jones D, Pritchard JK, Weihrauch D (2012) D-4F decreases myocardial inflammation in a model of murine scleroderma by decreasing interferon regulating factor-5 levels. Atherosclerosis, Thrombosis, Vascular Biology 32.
37. Kozyrev SV, Alarcon-Riquelme ME, (2007) The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40: 591-601.
38. Graham RR, Kozyrev SV, Baechler EC, Reddy MVPL, Plenge RM, et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nature Genetics 38: 550-555.